These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8174197)

  • 1. Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.
    Stewart DJ; Dulberg C; Molepo JM; Mikhael NZ; Montpetit VA; Redmond MD; Goel R
    Cancer Chemother Pharmacol; 1994; 34(1):14-22. PubMed ID: 8174197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods.
    Stewart DJ; Dulberg CS; Mikhael NZ; Redmond MD; Montpetit VA; Goel R
    Cancer Chemother Pharmacol; 1997; 40(4):293-308. PubMed ID: 9225947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
    Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA
    J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney.
    Mistry P; Merazga Y; Spargo DJ; Riley PA; McBrien DC
    Cancer Chemother Pharmacol; 1991; 28(4):277-82. PubMed ID: 1879045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats.
    Zhang P; Chen JQ; Huang WQ; Li W; Huang Y; Zhang ZJ; Xu FG
    Sci Rep; 2017 Mar; 7():44804. PubMed ID: 28300186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular metabolites of cisplatin in the rat kidney.
    Mistry P; Lee C; McBrien DC
    Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum concentrations in human autopsy tumor samples.
    Stewart DJ; Mikhael NZ; Nair RC; Kacew S; Montpetit V; Nanji A; Maroun JA; Howard K
    Am J Clin Oncol; 1988 Apr; 11(2):152-8. PubMed ID: 3358362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in serum uric acid level associated with cisplatin therapy. Correlation with liver but not kidney platinum concentrations.
    Nanji AA; Mikhael NZ; Stewart DJ
    Arch Intern Med; 1985 Nov; 145(11):2013-4. PubMed ID: 4062451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
    Hanigan MH; Gallagher BC; Taylor PT
    Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.
    Kelsen DP; Alcock N; Young CW
    Am J Clin Oncol; 1985 Feb; 8(1):77-80. PubMed ID: 4039530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An autopsy case of rectal cancer receiving cisplatin at total dose of 3.250 mg and platinum concentrations in autopsy tissue samples].
    Ishigaki H; Satoh S; Saitoh S; Yoshida Y; Ebina T; Satoh T; Nara K; Asano M; Oh-ishi S; Satoh F
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3805-8. PubMed ID: 2596863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
    Stewart DJ; Molepo JM; Green RM; Montpetit VA; Hugenholtz H; Lamothe A; Mikhael NZ; Redmond MD; Gadia M; Goel R
    Br J Cancer; 1995 Mar; 71(3):598-604. PubMed ID: 7880744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum accumulation in the kidney and changes in creatinine clearance following chemotherapy with cisplatin in humans.
    Uozumi J; Ueda T; Yasumasu T; Koikawa Y; Naito S; Kumazawa J; Kamura T; Nakano H; Sueishi K
    Urol Int; 1993; 51(2):57-61. PubMed ID: 8351755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats.
    Uehara T; Miyoshi T; Tsuchiya N; Masuno K; Okada M; Inoue S; Torii M; Yamate J; Maruyama T
    Hum Exp Toxicol; 2007 Oct; 26(10):767-80. PubMed ID: 18025048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
    Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
    Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.
    Nanji AA; Mikhael NZ; Stewart DJ
    Oncology; 1986; 43(1):33-5. PubMed ID: 3941800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin.
    Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; van Groeningen CJ; Hart GA; Pinedo HM
    Clin Pharmacol Ther; 1986 Feb; 39(2):136-44. PubMed ID: 3943271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tissue distribution of platinum after cis-diamminedichloroplatinum.
    Stewart DJ; Benjamin RS; Luna M; Feun L; Caprioli R; Seifert W; Loo TL
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):51-4. PubMed ID: 6891626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral thymoquinone administration ameliorates: the effect of cisplatin on brush border membrane enzymes, energy metabolism, and redox status in rat kidney.
    Farooqui Z; Shahid F; Abidi S; Parwez I; Khan F
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1271-1284. PubMed ID: 28944407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.